Akira Kurata

Dr. Akira Kurata


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2013 in European Radiology
Verified
Journal Article
Closed access
PDF file
AKAkira Kurata
Akira Kurata
ADAnoeshka Dharampal
Anoeshka Dharampal
ADAdmir Dedic
Admir Dedic
PFPim J. de Feyter
Pim J. de Feyter
GKGabriel P. Krestin
Gabriel P. Krestin
KNKoen Nieman
Koen Nieman

31 August 2014 in European Radiology
Verified
Journal Article
Closed access
PDF file
AKAkira Kurata
Akira Kurata
AKAtsushi Kono
Atsushi Kono
TSTsuyoshi Sakamoto
Tsuyoshi Sakamoto
TKTeruhito Kido
Teruhito Kido
TMTeruhito Mochizuki
Teruhito Mochizuki
KNKoen Nieman
Koen Nieman

1 July 2016 in Journal of Biomechanics
Verified
Journal Article
Closed access
JSJelle T.C. Schrauwen
Jelle T.C. Schrauwen
ACAdriaan Coenen
Adriaan Coenen
AKAkira Kurata
Akira Kurata
JWJolanda J. Wentzel
Jolanda J. Wentzel
ASAntonius F.W. van der Steen
Antonius F.W. van der Steen
FGFrank J.H. Gijsen
Frank J.H. Gijsen

23 December 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AKAkira Kurata
Akira Kurata
NKNaoto Kawaguchi
Naoto Kawaguchi
TKTeruhito Kido
Teruhito Kido
KIKatsuji Inoue
Katsuji Inoue
JSJun Suzuki
Jun Suzuki
TMTeruhito Mochizuki
Teruhito Mochizuki
The aim of this study was to investigate the correlation of the qualitative transmural extent of hypoperfusion areas (HPA) using stress dynamic whole-heart computed tomography perfusion (CTP) imaging by 256-slice CT with CTP-derived myocardial blood flow (MBF) for the estimation of the severity of coronary artery stenosis. Eleven patients underwent adenosine triphosphate (0.16 mg/kg/min, 5 min) stress dynamic CTP by 256-slice CT (coverage: 8 cm, 0.27 s/rotation), and 9 of the 11 patients underwent coronary angiography (CAG). Stress dynamic CTP (whole–heart datasets over 30 consecutive heart beats in systole without spatial and temporal gaps) was acquired with prospective ECG gating (effective radiation dose: 10.4 mSv). The extent of HPAs was visually graded using a 3-point score (normal, subendocardial, transmural). MBF (ml/100g/min) was measured by deconvolution. Differences in MBF (mean ± standard error) according to HPA and CAG results were evaluated. In 27 regions (3 major coronary territories in 9 patients), 11 coronary stenoses (> 50% reduction in diameter) were observed. In 353 myocardial segments, HPA was significantly related to MBF (P < 0.05; normal 295 ± 94; subendocardial 186 ± 67; and transmural 80 ± 53). Coronary territory analysis revealed a significant relationship between coronary stenosis severity and MBF (P < 0.05; non-significant stenosis [< 50%], 284 ± 97; moderate stenosis [50–70%], 184 ± 74; and severe stenosis [> 70%], 119 ± 69). The qualitative transmural extent of HPA using stress whole-heart dynamic CTP imaging by 256-slice CT exhibits a good correlation with quantitative CTP-derived MBF and may aid in assessing the hemodynamic significance of coronary artery disease.

1 January 2020 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
PDF file
KHKuniaki Hirai
Kuniaki Hirai
TKTeruhito Kido
Teruhito Kido
TKTomoyuki Kido
Tomoyuki Kido
RORyo Ogawa
Ryo Ogawa
YTYuki Tanabe
Yuki Tanabe
TMTeruhito Mochizuki
Teruhito Mochizuki
Coronary magnetic resonance angiography (CMRA) is a promising technique for assessing the coronary arteries. However, a disadvantage of CMRA is the comparatively long acquisition time. Compressed sensing (CS) can considerably reduce the scan time. The aim of this study was to verify the feasibility of CS CMRA scanning during the waiting time between contrast injection and late gadolinium enhancement (LGE) scan in a clinical protocol. Fifty clinical patients underwent contrast-enhanced CS CMRA and conventional CMRA on a 3 T CMR scanner. After contrast injection, CS CMRA was scanned during the waiting time for LGE CMR. A conventional CMRA scan was performed after LGE CMR. We assessed acquisition times and coronary artery image quality for each segment on a 4-point scale. Visible vessel length, sharpness and diameter of right (RCA), left anterior descending (LAD), and left circumflex (LCX) coronary arteries were also quantitatively compared among the scans. All CS CMRA scans were successfully performed within the LGE waiting time. The median total scan time was 207 s (163, 259 s) for CS and 785 s (698, 975 s) for conventional CMRA (p < 0.001). No significant differences were observed in image quality scores, vessel length measurements, sharpness, and diameter between CS and conventional CMRA. We could achieve all CS CMRA scans within the LGE waiting time. Contrast-enhanced CS CMRA could considerably shorten the scan time while maintaining image quality compared with conventional CMRA.

17 June 2014 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
ADAdmir Dedic
Admir Dedic
AKAkira Kurata
Akira Kurata
MLMarisa Lubbers
Marisa Lubbers
WMWillem Bob Meijboom
Willem Bob Meijboom
BDBas van Dalen
Bas van Dalen
KNKoen Nieman
Koen Nieman
Aims Non-culprit plaques are responsible for a substantial number of future events in patients with acute coronary syndrome (ACS). In this study, we evaluated the prognostic implications of non-culprit plaques seen on coronary computed tomography angiography (CTA) in patients with ACS. Methods and results Coronary CTA was performed in 169 patients (mean 59 ± 11 years, 129 males) admitted with ACS. Data sets were assessed for the presence of obstructive non-culprit plaques (>50% luminal narrowing), segment involvement score, and quantitative measures of plaque burden, after censoring initial culprit plaques. Follow-up was performed for the occurrence of major adverse cardiovascular events (MACEs) unrelated to the initial culprit plaque; cardiac death, second ACS, or coronary revascularization after 90 days. After a median follow-up of 4.8 (IQR 2.6–6.6) years, MACE occurred in 36 (24%) patients: 6 cardiac deaths, 16 second ACS, and 14 coronary revascularizations. Dyslipidaemia (hazard ratio [HR] 3.1 [95% confidence interval 1.5–6.6]) and diabetes mellitus (HR 4.8 [2.3–10.3]) were univariable clinical predictors of MACE. Patients with remaining obstructive non-culprit plaques (HR 3.66 [1.52–8.80]) and higher plaque burden index (HR 1.22 [1.01–1.48]) had a more risk of MACE. In multivariate analysis, with diabetes, dyslipidaemia, and plaque burden index, obstructive non-culprit plaques (HR 3.76 [1.28–11.09]) remained an independent predictor of MACE. Conclusion Almost a quarter of the study population experienced a new event arising from a non-culprit plaque during a follow-up of almost 5 years. ACS patients with remaining obstructive non-culprit plaques or high plaque burden have an increased risk of future MACE.